Health In Tech Sees FY2026 Sales $45.000M-$50.000M vs $42.035M Est
Benzinga Newsdesk 7 months ago
NewsGuidance
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Health In Tech (NASDAQ:HIT) sees FY2026 sales of $45.000 million-$50.000 million vs $42.035 million analyst estimate.
Health In Tech (NASDAQ:HIT) sees FY2026 sales of $45.000 million-$50.000 million vs $42.035 million analyst estimate.